4//SEC Filing
KLEMP WALTER V 4
Accession 0001437749-25-020802
CIK 0001659617other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:00 PM ET
Size
8.2 KB
Accession
0001437749-25-020802
Insider Transaction Report
Form 4
KLEMP WALTER V
DirectorCEO and President
Transactions
- Tax Payment
Common Stock
2025-06-16$0.69/sh−406$278→ 58,296 total - Exercise/Conversion
Restricted Stock Units
2025-06-16−1,667→ 370,075 total→ Common Stock (1,667 underlying) - Exercise/Conversion
Common Stock
2025-06-16+1,667→ 58,702 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards
- [F3]On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Moleculin Biotech, Inc.
CIK 0001659617
Entity typeother
Related Parties
1- filerCIK 0000938419
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 9:00 PM ET
- Size
- 8.2 KB